Compare TFX & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TFX | AMRX |
|---|---|---|
| Founded | 1943 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.0B |
| IPO Year | 1994 | 2018 |
| Metric | TFX | AMRX |
|---|---|---|
| Price | $119.32 | $14.38 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $137.11 | $13.25 |
| AVG Volume (30 Days) | 931.1K | ★ 3.5M |
| Earning Date | 05-27-2026 | 03-31-2026 |
| Dividend Yield | ★ 1.22% | N/A |
| EPS Growth | N/A | ★ 20.83 |
| EPS | N/A | ★ 0.11 |
| Revenue | ★ $3,047,324,000.00 | N/A |
| Revenue This Year | $9.54 | $10.02 |
| Revenue Next Year | $10.52 | $6.51 |
| P/E Ratio | ★ N/A | $132.55 |
| Revenue Growth | ★ 2.45 | N/A |
| 52 Week Low | $100.18 | $6.69 |
| 52 Week High | $143.32 | $15.42 |
| Indicator | TFX | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 65.36 | 54.49 |
| Support Level | $117.58 | $12.50 |
| Resistance Level | $126.71 | $15.00 |
| Average True Range (ATR) | 4.69 | 0.38 |
| MACD | 1.50 | -0.09 |
| Stochastic Oscillator | 95.68 | 14.96 |
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.